Saturday 17 October 2026
Export ESTA’s income statement to Excel — free account
Establishment Labs Holdings Inc.
ESTA Healthcare Medical Devices
Establishment Labs Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $211.1 million, up 27.1% from fiscal 2024. In the quarter to June 2026, revenue grew 31.7%, EPS grew 31.6%, free cash flow grew 2.75% and total debt rose 18.3%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
59.18
2.18
−3.55%
Follow ESTA
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | 3 | 3 | 5 | 5 | 3 | 2 | 5 | 5 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | — | 5.70 | 3.54 | 5.76 | 9.89 | 3.30 | 0.05 | 1.46 | 2.73 |
P/S ratio |
7.97 | 7.97 | 7.77 | 6.34 | 10.36 | 12.79 | 9.49 | 4.12 | 7.81 | 10.23 |
Altman Z″-Score (non-manufacturers) |
(17.06) | (8.39) | 2.36 | (0.71) | 0.79 | (1.61) | (2.20) | (3.04) | (1.65) | (2.10) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | (1.99) | (1.57) | (2.79) | (3.22) | (2.70) | (2.64) | (1.84) | (2.40) | (2.30) |
P/Operating CF |
(42.32) | (42.32) | (56.10) | (141.13) | 255.57 | (210.19) | (109.45) | (83.54) | (62.53) | (13,325.34) |
P/B ratio |
160.25 | 160.25 | 6.85 | 14.34 | 11.71 | 31.93 | 0.00 | 37.00 | 24.44 | 91.68 |
Price to Tangible BV |
0.00 | 0.00 | 7.26 | 15.91 | 12.48 | 35.30 | 0.00 | 68.46 | 32.27 | 174.15 |
EV/Sales |
8.61 | 8.61 | 7.63 | 6.70 | 10.21 | 12.95 | 10.29 | 5.15 | 8.72 | 11.14 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(12.79) | (12.79) | (13.77) | (20.01) | (69.08) | (59.57) | (31.91) | (9.61) | (24.74) | (46.22) |
EV/FCF |
(12.56) | (12.56) | (11.78) | (15.89) | (63.19) | (47.27) | (19.14) | (7.52) | (19.55) | (40.82) |
Quick Ratio |
0.13 | 0.42 | 4.27 | 2.60 | 4.00 | 2.44 | 2.61 | 1.52 | 2.28 | 1.86 |
Current Ratio |
0.23 | 0.69 | 6.05 | 4.12 | 5.11 | 3.55 | 3.85 | 3.06 | 3.56 | 3.04 |
Net Debt/EBITDA |
(1.37) | 0.57 | 1.44 | (0.38) | 1.54 | 0.08 | (3.09) | (2.47) | (3.05) | (6.03) |
Debt/Assets |
72.09% | 1.05% | 19.15% | 41.31% | 31.86% | 37.20% | 83.13% | 70.26% | 63.31% | 69.30% |
Debt/Equity |
(0.81) | (0.12) | 0.32 | 1.22 | 0.66 | 1.02 | (21.44) | 10.26 | 4.14 | 10.51 |
Asset Turnover |
0.46 | 0.80 | 0.70 | 0.77 | 0.62 | 0.86 | 0.92 | 0.69 | 0.54 | 0.60 |
Operating CF/Net income |
0.64 | 0.92 | 1.61 | 0.79 | 0.33 | 0.67 | 0.69 | 1.13 | 0.69 | 1.00 |
Capex/Depreciation |
(17.83) | (0.49) | (0.63) | (2.36) | (0.22) | (1.16) | (8.02) | (5.03) | (2.05) | (0.64) |
Interest Coverage |
(4.64) | (1.92) | (2.71) | (3.56) | (2.98) | (2.77) | (3.37) | (4.22) | (2.40) | (1.54) |
| 140.92% | 221.93% | (65.45%) | (69.94%) | (66.54%) | (65.46%) | (353.48%) | (1,537.75%) | (236.67%) | (133.25%) | |
| (51.14%) | (80.54%) | (24.30%) | (32.73%) | (27.94%) | (27.80%) | (42.90%) | (32.73%) | (27.49%) | (14.51%) | |
ROIC |
0.00% | 0.00% | (38.08%) | (38.60%) | (43.33%) | (31.92%) | (24.56%) | (24.32%) | (17.14%) | (12.47%) |
Return on Tangible Assets |
76.88% | 766.46% | (22.00%) | (42.86%) | (31.09%) | (41.12%) | (46.41%) | (40.27%) | (33.47%) | (20.98%) |
Average Days of Receivables |
122.55 | 137.96 | 105.24 | 92.78 | 82.45 | 70.41 | 79.96 | 103.69 | 142.90 | 134.01 |
Research and Development Expense of Revenue |
13.84% | 19.79% | 20.73% | 16.74% | 16.29% | 14.46% | 12.53% | 16.00% | 11.87% | 9.59% |
Selling, General and Administrative Expense of Revenue |
117.11% | 88.87% | 77.27% | 79.06% | 78.68% | 72.80% | 77.91% | 88.15% | 84.21% | 78.20% |
Intangible Assets out of Total Assets |
0.08 | 0.07 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.03 | 0.04 | 0.03 |
Share Based Compensation of Revenue |
15.78% | 9.52% | 11.96% | 7.29% | 6.76% | 8.22% | 8.26% | 9.00% | 9.26% | 5.60% |
Graham Net Nets |
(0.04) | (0.04) | 0.11 | 0.03 | 0.06 | 0.02 | (0.05) | (0.11) | (0.04) | (0.04) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.81 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(14.35%) | (14.35%) | (4.54%) | (6.72%) | (4.38%) | (2.53%) | (4.89%) | (11.43%) | (6.47%) | (2.39%) |
Free Cash Flow Yield |
(8.60%) | (8.60%) | (8.33%) | (6.64%) | (1.56%) | (2.14%) | (5.67%) | (16.61%) | (5.71%) | (2.67%) |
Revenue per Share |
3.05 | 3.39 | 3.53 | 4.36 | 3.63 | 5.28 | 6.61 | 6.45 | 5.90 | 7.13 |
Operating CF per Share |
(2.20) | (3.12) | (1.95) | (1.46) | (0.54) | (1.15) | (2.13) | (3.46) | (2.08) | (1.72) |
Capex per Share |
(1.63) | (0.09) | (0.10) | (0.38) | (0.05) | (0.30) | (1.42) | (0.96) | (0.55) | (0.23) |
Free Cash Flow per Share |
(3.83) | (3.22) | (2.06) | (1.84) | (0.59) | (1.45) | (3.56) | (4.42) | (2.63) | (1.94) |
Cash per Share |
0.07 | 1.06 | 3.03 | 1.83 | 3.63 | 2.23 | 2.71 | 1.56 | 3.21 | 2.55 |
Shareholders Equity per Share |
(4.08) | (0.49) | 4.00 | 1.93 | 3.22 | 2.12 | (0.33) | 0.72 | 1.89 | 0.80 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(4.08) | (0.49) | 4.00 | 1.93 | 3.22 | 2.12 | (0.33) | 0.72 | 1.89 | 0.80 |
Free Cash Flow |
(24.82) | (32.91) | (35.66) | (37.75) | (13.68) | (34.69) | (86.96) | (113.06) | (74.08) | (57.61) |
Working Capital |
(42.05) | (18.05) | 82.99 | 72.60 | 106.40 | 81.38 | 110.95 | 117.75 | 174.76 | 167.80 |
Capital Expenditures |
(10.55) | (0.94) | (1.77) | (7.77) | (1.17) | (7.16) | (34.79) | (24.55) | (15.56) | (6.72) |
Net Current Asset Value |
(43.48) | (22.73) | 52.35 | 18.92 | 50.87 | 24.48 | (69.34) | (75.34) | (50.70) | (83.68) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.53 | 0.03 | 0.03 | 0.09 | 0.01 | 0.06 | 0.22 | 0.15 | 0.09 | 0.03 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.04 | 0.14 | 0.22 | 0.20 | 0.33 | 0.33 | 0.08 | 0.06 | 0.10 | 0.14 |
Cash ROIC |
534.22% | (510.25%) | (24.69%) | (30.10%) | (6.53%) | (22.23%) | (37.22%) | (45.74%) | (20.41%) | (16.62%) |
Accounts Receivable Turnover |
2.00 | 3.51 | 3.98 | 4.43 | 4.04 | 5.82 | 5.40 | 4.01 | 2.97 | 2.96 |
Accounts Payable Turnover |
1.18 | 2.07 | 3.26 | 4.18 | 3.20 | 3.41 | 3.19 | 1.89 | 1.31 | 1.47 |
Inventory Turnover |
1.08 | 1.89 | 1.32 | 1.30 | 1.24 | 1.60 | 1.70 | 1.00 | 0.71 | 0.79 |
Average Days of Payables |
273.80 | 196.29 | 90.76 | 109.02 | 110.29 | 127.99 | 132.70 | 261.16 | 289.16 | 242.94 |
Days of Inventory on Hand |
180.53 | 283.18 | 361.44 | 301.43 | 263.31 | 251.19 | 242.32 | 498.62 | 508.84 | 482.46 |
Average Receivables |
9.88 | 9.88 | 15.38 | 20.21 | 20.95 | 21.78 | 29.93 | 41.17 | 55.96 | 71.25 |
Average Payables |
8.21 | 8.21 | 7.69 | 8.30 | 10.04 | 12.10 | 17.25 | 30.83 | 43.19 | 43.93 |
Average Inventory |
8.99 | 8.99 | 19.01 | 26.75 | 25.94 | 25.81 | 32.50 | 58.03 | 79.12 | 82.19 |
Average Assets |
43.33 | 43.33 | 86.83 | 116.55 | 136.46 | 147.96 | 175.30 | 239.85 | 307.74 | 352.00 |
Average Common Equity |
(15.72) | (15.72) | 32.24 | 54.55 | 57.29 | 62.85 | 21.28 | 5.11 | 35.75 | 38.32 |
Columns are period end dates